
Telmihans H 40mg/12.5mg Tablet
Marketer
Caligen Labs Pvt Ltd
Salt Composition
Telmisartan (40mg) + Hydrochlorothiazide (12.5mg)
Overview Telmihans H 40mg/12.5mg Tablet
Combiflo H 40mg/12.5mg tablets combine two active ingredients to manage hypertension. This dual-action formulation is typically prescribed when a single medication proves insufficient. Effectively controlling blood pressure significantly lowers your risk of future cardiovascular events, such as strokes and heart attacks. This medication can be administered with or without food, with dosage tailored to individual patient response and health status. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. The formulation includes a diuretic, promoting increased urination; therefore, avoid late-day administration (within four hours of bedtime). Continued use, even when feeling well, is vital for optimal therapeutic effect. Hypertension often presents asymptomatically. Dizziness is the most frequently reported side effect, while fatigue, nausea, dyspnea, and cardiac arrhythmias are less common. Increased urination is an intended effect, contributing to blood pressure regulation, not a side effect. While rarer side effects exist, consult the accompanying patient information leaflet and your doctor regarding any persistent or bothersome symptoms. Dosage adjustments or alternative therapies may be considered. Avoid potassium supplements and salt substitutes unless specifically advised by your doctor. This medication is contraindicated during pregnancy and lactation. Prior consultation with your doctor is necessary if you have pre-existing kidney or liver disease, cardiac issues, or diabetes. Alcohol consumption may exacerbate blood pressure reduction and increase side effect incidence.
Primary Ingredients of Telmihans H 40mg/12.5mg Tablet
No text provided to rephrase.
Uses of Telmihans H 40mg/12.5mg Tablet
Managing Elevated Blood Pressure
Major Benefits of Telmihans H 40mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmihans H 40mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telmihans H 40mg/12.5mg Tablet:
- Fatigue
- Dizziness
- Nausea
- Decreased magnesium level in blood
How to use Telmihans H 40mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmihans H 40mg/12.5mg Tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Telmihans H 40mg/12.5mg Tablet works:
Each Telmihans H 40mg/12.5mg tablet contains a dual medication formulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Telmihans H 40mg/12.5mg tablets may pose safety risks; physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Use of Telmihans H 40mg/12.5mg tablets is contraindicated during pregnancy due to established risks to the fetus. Exceptions may be made in life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Telmihans H 40mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Telmihans H 40mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these side effects arise.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmihans H 40mg/12.5mg tablets, as dosage modification may be necessary. A physician's consultation is advised. Telmihans H 40mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telmihans H 40mg/12.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmihans H 40mg/12.5mg Tablet :
Should you forget a Telmihans H 40mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmihans H 40mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
